Published TCIMAIL newest issue No.198
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 7361-61-7 | Product Number: X0069
Xylazine
×
![]()
×
Purity: >97.0%(T)(HPLC)
Synonyms:
- N-(2,6-Dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine
- 2-(2,6-Dimethylphenylamino)-5,6-dihydro-4H-1,3-thiazine
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 5G |
€71.00
|
Contact Us | 2 |
|
| 25G |
€216.00
|
Contact Us | 9 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | X0069 |
Purity / Analysis Method 
|
>97.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__2H__1__6N__2S = 220.33 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive |
| CAS RN | 7361-61-7 |
| Reaxys Registry Number | 519476 |
| MDL Number | MFCD00057908 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 97.0 area% |
| Purity(Nonaqueous Titration) | min. 97.0 % |
| Melting point | 138.0 to 142.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 140 °C |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H301 : Toxic if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
Related Laws:
| EC Number | 230-902-1 |
| RTECS# | XJ0776300 |
Transport Information:
| UN Number | UN2811 |
| Class | 6.1 |
| Packing Group | III |
| HS Number | 2934999090 |
Application
Xylazine: A α2-Adrenegic Receptor Agonist
Xylazine and its hydrochloride [X0059] are α2-adrenegic receptor agonists, and decrease the release of norepinephrine and dopamine in the central nervous system resulting in effects such as analgesia, sedation and muscle relaxation. Xylazine is used as a veterinary medicine for sedation, and is particularly used worldwide as a short- acting sedative in general equine and racing practice. (The product is for research purpose only.)
References
- Xylazine - a review of its pharmacology and use in veterinary medicine
- Alpha2 adrenoceptor agonists in the horse – a review
- Determination of xylazine and its metabolites by GC-MS in equine urine for doping analysis
- Re-evaluation of the pharmacokinetics of xylazine administered to Thoroughbred horses
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.